Sativa Wellness - New Test for Travellers
RNS Number : 4135U
Sativa Wellness Group Inc.
06 April 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION (INCLUDING THE UNITED STATES) WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

Sativa Wellness Group Inc.
("Sativa" or "Sativa Wellness" the "Company" or the "Group")

6 April 2021

 

New Test for Travellers

 

Sativa Wellness Group is pleased to announce that it is now listed on the UK government website to offer 2 and 8 day quarantine tests (the "Return Tests") for travellers returning to the UK. The Return Tests are a significant addition to the Company's current offering of COVID 19 tests for travellers leaving the UK and will impact positively on the Company's revenues that continue to build.

There are now 24 Goodbody clinics offering COVID-19 testing and the Company is confident that its target of 30 clinics will be met by the end of April.

Geremy Thomas Executive Chairman says "Goodbody clinic customers can now arrange all their travel testing in one go which is a better service for them and a revenue boost for us".


The Directors of the Company accept responsibility for the contents of this announcement.

On behalf of the Board of Directors,

 

Geremy Thomas

Executive Chairman

Sativa Wellness Group Inc.

+44 (0) 20 7971 1255

enquiries@sativawellnessgroup.com

 www.sativawellnessgroup.com

Joseph Colliver

Chief Financial Officer

Sativa Wellness Group Inc.

+44 (0) 20 7971 1255

enquiries@sativawellnessgroup.com

 www.sativawellnessgroup.com

 

 

 

 

AQSE Growth Market Corporate Adviser

Peterhouse Capital Limited

Guy Miller/Allie Feuerlein

+ 44 (0) 20 7220 9795 

 

 

This information is provided by RNS, the news service of the . RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXEAXLSESFFEFA ]]>